Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus

por Chen, Kristen L., Krain, Rebecca L., Werth, Victoria P.
Publicado 2019

AB004. Evaluating differences in meaningful change in disease activity between different races and clinical subtypes affected by cutaneous lupus erythematosus

por Chakka, Srita, Krain, Rebecca, Ahmed, Sarah, Concha, Josef Symon S., Werth, Victoria P.
Publicado 2021

AB005. Assessing meaningful changes in disease activity as clinical trial clinical efficacy measures for cutaneous lupus erythematosus

por Chakka, Srita, Krain, Rebecca, Ahmed, Sarah, Concha, Josef Symon S., Feng, Rui, Werth, Victoria P.
Publicado 2021

AB021. Comparing the performance of two interferon-gamma release assays in autoimmune skin disease patients: a prospective study

por Krain, Rebecca L., Gaffney, Rebecca G., Keyes, Emily R., Feng, Rui, Werth, Victoria P.
Publicado 2021

The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review

por Chakka, Srita, Krain, Rebecca L., Concha, Josef Symon S., Chong, Benjamin F., Merola, Joseph F., Werth, Victoria P.
Publicado 2021

Cutaneous lupus concerns from the patient perspective: a qualitative study

por Yan, Daisy, Zamalin, Danielle, Chakka, Srita, Krain, Rebecca, Concha, Josef, Feng, Rui, Ahmed, Sarah, Okawa, Joyce, Werth, Victoria P
Publicado 2021

Assessing the Correlation Between Disease Severity Indices and Quality of Life Measurement Tools in Pemphigus

por Krain, Rebecca L., Kushner, Carolyn J., Tarazi, Meera, Gaffney, Rebecca G., Yeguez, Andrea C., Zamalin, Danielle E., Pearson, David R., Feng, Rui, Payne, Aimee S., Werth, Victoria P.
Publicado 2019